Clinical Trial Update: Effects of Inhibiting Early Inflammation in Kidney Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effects of inhibiting early inflammation in kidney transplant patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplant | Phase 2 | Status: COMPLETED | Results posted: 2022-08-16